RxDoctor Payments Data

David Patzer, MD

Child & Adolescent Psychiatry · Nashville, TNNPI 1376780841

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,343 and has fallen 58.0% since, to $564 in 2025. Among child & adolescent psychiatry clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,598in general payments, 2019–2025

Across 173 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$650
  • Otsuka America Pharmaceutical, Inc.$424
  • AbbVie$375
  • Axsome Therapeutics, Inc.$245
  • Neurocrine Biosciences, Inc.$185
  • Teva Pharmaceuticals USA, Inc.$165
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$3,598100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,598 in reported general payments places this provider in the 90th percentile of 43 child & adolescent psychiatry providers in Tennessee.

See all child & adolescent psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$65,385
Medicare patients
67
Services billed
516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl17$31,226
TrintellixVortioxetine Hydrobromide19$9,258
Duloxetine Hcl78$1,465
Bupropion XlBupropion Hcl28$921
Buspirone Hcl53$597
Pregabalin27$481
Fluoxetine Hcl33$435
Desvenlafaxine Succinate ErDesvenlafaxine Succinate17$417
Alprazolam ErAlprazolam11$411
Diazepam33$339
Alprazolam59$335
Clonazepam37$295
Lamotrigine38$247
Mirtazapine14$215
Escitalopram Oxalate16$178

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$29$31,22617 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$73$9,25819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 43 child & adolescent psychiatry providers in Tennessee.

Other child & adolescent psychiatry in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →